Growing community of inventors

Lynge, Denmark

Philip Kusk

Average Co-Inventor Count = 2.42

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 14

Philip KuskLars Ulrik Wahlberg (5 patents)Philip KuskLars U Wahlberg (2 patents)Philip KuskTeit E Johansen (1 patent)Philip KuskJens Tornøe (3 patents)Philip KuskNikolaj Blom (1 patent)Philip KuskMette Grønborg (1 patent)Philip KuskThomas Nordahl Petersen (1 patent)Philip KuskSøren Brunak (1 patent)Philip KuskMette Gronborg (1 patent)Philip KuskJens Tornoe (1 patent)Philip KuskWilliam P Sisk (1 patent)Philip KuskLars Ulrik Wahlberg (0 patent)Philip KuskPhilip Kusk (7 patents)Lars Ulrik WahlbergLars Ulrik Wahlberg (16 patents)Lars U WahlbergLars U Wahlberg (7 patents)Teit E JohansenTeit E Johansen (16 patents)Jens TornøeJens Tornøe (3 patents)Nikolaj BlomNikolaj Blom (3 patents)Mette GrønborgMette Grønborg (1 patent)Thomas Nordahl PetersenThomas Nordahl Petersen (1 patent)Søren BrunakSøren Brunak (1 patent)Mette GronborgMette Gronborg (1 patent)Jens TornoeJens Tornoe (1 patent)William P SiskWilliam P Sisk (1 patent)Lars Ulrik WahlbergLars Ulrik Wahlberg (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Nsgene A/s (3 from 19 patents)

2. Gloriana Therapeutics Sarl (2 from 4 patents)

3. Hoba Therapeutics Aps (1 from 4 patents)

4. Biogen Idec Ma Inc. (216 patents)


7 patents:

1. 12396957 - Cell lines and their use in encapsulated cell biodelivery

2. 10888526 - Cell lines and their use in encapsulated cell biodelivery

3. 9884023 - Cell lines and their use in encapsulated cell biodelivery

4. 9845344 - Therapeutic use of a growth factor, NsG33

5. 9121037 - Cell lines and their use in encapsulated cell biodelivery

6. 8741340 - Cell lines and their use in encapsulated cell biodelivery

7. 7601518 - Secretion of neublastin

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…